Association of systemic lupus erythematosus and Sjögren's syndrome;Szisztémás lupus erythematosus és Sjögren- szindróma társult eseteinek elemzése

Orvosi Hetilap

Volumn 146, Issue 50, 2005, Pages 2533-2538

  Szántó, Antónia ^a   Kiss, Emese ^a   Sas, Attila ^b   Szegedi, Gyula ^a,c   Zeher, Margit ^a,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b III Belgyogyaszati Klinika   (Hungary)

^c MTA DE Autoimmun Kórképek Kutatócsoport ^*  (Hungary)

Author keywords

Sj gren's syndrome; Systemic lupus erythematosus

Indexed keywords

DNA ANTIBODY; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; AUTOANTIBODY;

ANEMIA; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; AGED; AUTOIMMUNE THYROIDITIS; BLOOD; COMORBIDITY; COMPARATIVE STUDY; DERMATITIS; FEMALE; HUNGARY; IMMUNOLOGY; MALE; MIDDLE AGED; MYOSITIS; PATHOLOGY; PERIPHERAL NERVOUS SYSTEM; PREVALENCE; RAYNAUD PHENOMENON; SKELETAL MUSCLE; VASCULITIS;

ADULT; AGED; ANEMIA; AUTOANTIBODIES; COMORBIDITY; DERMATITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNGARY; LEUKOPENIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPENIA; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; PERIPHERAL NERVOUS SYSTEM; PREVALENCE; RAYNAUD DISEASE; SJOGREN'S SYNDROME; THYROIDITIS, AUTOIMMUNE; VASCULITIS;

EID: 33644856736     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bakó Gy., Bíró E., Czirják L. és mtsai: Autoimmun pajzsmirigy betegségek társulása egyéb autoimmun betegségekkel. MBA, 1988, 51, 273-275.
2. Bossuyt, X., Frans, J., Hendrickx, A. és mtsai: Detection of anti-SSA antibodies by indirect immunofluorescence. Clin. Chem., 2004, 50, 2361-2369.
3. Cooper, G. S., Berrit, C: The epidemiology of autoimmune diseases. Autoimmun. Rev., 2003, 2, 119-125.
4. Galeazzi, M., Sebastiani, G. D., Morozzi, G. és mtsai: HLA Class H DNA Typing in a Large Series of European Patients with Systemic Lupus Erythematosus. Medicine, 2002, 81, 169-178.
5. Galli, M., Luciani, D., Bertolini, G. és mtsai: Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood, 2003, 101, 1827-1832.
6. Heaton, J. M.: Sjögren's syndrome and systemic lupus erythematosus. Br. Med. J., 1959, 1, 466-469.
7. Hietaharju, A., Jantti, V., Korpela, M. és mtsai: Nervous system involvement in systemic lupus erythematosus, Sjogren syndrome and scleroderma. Acta Neurol. Scand., 1993, 88, 299-308.
8. Hochberg, M. C.: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 1997, 40, 1725.
9. Jimenez, S., Cervera, R., Font, J. és mtsai: The epidemiology of systemic lupus erythematosus. Clin. Rev. Allergy. Immunol., 2003, 25, 3-12.
10. Kassan, S. S., Moutsopoulos, H. M.: Clinical manifestations and early diagnosis of Sjogren syndrome. Arch. Intern. Med., 2004, 164, 1275-1284.
11. Kelly, J. A., Moser, K. L., Harley, B. J.: The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun., 2002, (Suppl. 1.), Oct., 3. S71-S85.
12. Lakos, G., Kiss, E., Tarján, P. és mtsai: Isotype distribution and clinical relevance of anti-β2-glycoprotein-I antibodies: importance of IgA isotype. Clin. Exp. Immunol., 1999, 117, 574-579.
13. Magro, C. M., Crowson, A. N.: The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutan erythematosus. Am. J. Dermatopathol., 1999, 21, 129-137.
14. Manoussakis, M. N., Georgopoulou, C., Zintzaras, E. és mtsai: Sjögren's syndrome associated with systemic lupus erythematosus. Arthritis Rheum., 2004, 50, 882-891.
15. Manson, J. J., Isenberg, D. A.: The pathogenesis of systemic lupus erythematosus. Neth. J. Med., 2003, 61, 343-346.
16. 16. Manthorpe, R., Morling, N., Platz, P. és mtsai: HLA-D antigen frequencies in Sjögren's syndrome. Scand. J. Rheumatology., 1981, 10, 124-128.
17. Mitrovic, D., Popovic, M., Stefanovic, D. és mtsai: Antiphospholipid syndrome in systemic connective tissue diseases. Vojnosanit Pregl., 1998, 55, 29-33.
18. Petrányi Gy. (szerk.): Klinikai immunológia. Medicina Kiadó, Budapest, 2000, 429-439. és 479-485. old.
19. Ramos-Casals, M., Tzioufas, A. G., Font, J.: Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann. Rheum. Dis., 2005, 64, 347-354.
20. Roitberg-Tambur, A., Friedmann, A., Safirman, C. és mtsai: Molecular analysis of HLA class II genes in primary Sjögren's syndrome: a study of Israeli Jewish and Greek non-Jewish patients. Hum. Immunol., 1993, 36, 235-242.
21. Ruiz-Irastorza, G., Khamashta, M. A., Castellino, G. és mtsai: Systemic lupus erythematosus. Lancet 2001, 357, 1027-1032.
22. Sawalha, A. H., Potts, R., Schmid, W. R. és mtsai: The genetics of primary Sjogren's syndrome. Curr. Rheumatol. Rep., 2003, 5, 324-332.
23. Setty Y. N., Komatireddy, G. R.: Antiphospholipid antibodies in systemic lupus erythematosus and the antiphospholipid syndrome. Front. Biosci., 2001, 1, 207-212.
24. Sutcliffe, N., Stoll, T., Pyke, S. és mtsai: Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS. J. Rheumatol., 1998, 25, 63-68.
25. Szegedi Gy., Zeher M., Bakó Gy. (szerk.): Klinikai immunológia. Springer Kiadó, Budapest, 1999, 168-181. és 144-160. old.
26. Tektonidou, M. G., Anapliotou, M., Vlachoyiannopoulos, P. és mtsai: Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann. Rheum. Dis., 2004, 63, 1159-1161.
27. Tsao, B. P.: The genetics of human systemic lupus erythematosus. Trends. Immunol., 2003, 24, 595-602.
28. Tunc, R., Gonen, M. S., Acbay, O. és mtsai: Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study. Ann. Rheum. Dis., 2004, 63, 575-577.
29. Tzioufas, A. G., Wassmuth, R., Dafni, U. G. ës mtsai: Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome: a European multicentre study. Ann. Rheum. Dis., 2002, 61, 398-404.
30. Veres K., Lakos G., Kappelmayer J. ës mtsai: Antifoszfolipid antitestek Sjögren-szindrómában. Magy. Rheum., 1998, 39, 207-211.
31. Vitali, C., Bombardieri, S., Jonsson, R. és mtsai: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis., 2002, 61, 554-558.
32. Yamamoto, K.: Pathogenesis of Sjögren's syndrome. Autoimmunity Rev., 2003, 2, 13-18.
33. Zeher M., Bodolay E., Czirják L. és mtsai: A poliszisztémás autoimmun betegségekhez társult Sjögren-szindrómáról. A szekunder Sjögren- szindróma klinikai sajátosságai. Magy. Rheumat., 1990, 31, 219-229.
34. Zeher M., Szekanecz Z., Csontos Gy. és mtsai: Klinikai és immunológiai sajátosságok vizsgálata primer Sjögren syndromában. MBA, 1989, 42, 31.
35. Zeher M., Szegedi Gy.: Primer Sjögrenszindróma extraglandularis tünetekkel. Ajánlott kritériumrendszer a klinikai aktivitás meghatározásához. Magy. Rheumat., 1990, 31, 93-96.
36. Zeher M., Szegedi Gy.: A Sjögren- szindrómáról. Orvosképzés, 1988, 63, 55-67.
37. Zufferey, P., Meyer, O. C., Bourgeois, P. és mtsai: Primary systemic Sjogren syndrome (SS) preceding systemic lupus erythematosus: a retrospective study of 4 cases in a cohort of 55 SS patients. Lupus, 1995, 4, 23-27.